Atsushi Imai Selected Research

Buserelin (Suprefact)

1/2016	Minodronic acid suppresses gonadotropin-releasing hormone agonist-induced bone remodeling biomarkers: a retrospective pilot study.
5/2002	Evidence for hormone-responsive cleavage of gonadotropin-releasing hormone by the plasma membrane of ovarian cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atsushi Imai Research Topics

Disease

47	Neoplasms (Cancer) 01/2022 - 03/2002
27	Squamous Cell Carcinoma of Head and Neck 01/2022 - 12/2010
21	Prostatic Neoplasms (Prostate Cancer) 10/2020 - 03/2003
13	Head and Neck Neoplasms (Head and Neck Cancer) 08/2020 - 01/2012
12	Urinary Bladder Neoplasms (Bladder Cancer) 10/2020 - 01/2008
10	Carcinoma (Carcinomatosis) 03/2020 - 03/2002
9	Ovarian Neoplasms (Ovarian Cancer) 08/2015 - 03/2002
8	Carcinogenesis 08/2020 - 01/2012
7	Non-Muscle Invasive Bladder Neoplasms 01/2021 - 09/2015
7	Neoplasm Metastasis (Metastasis) 01/2020 - 03/2003
5	Schizophrenia (Dementia Praecox) 01/2022 - 02/2019
5	Renal Cell Carcinoma (Grawitz Tumor) 02/2017 - 07/2012
4	Chronic Renal Insufficiency 01/2021 - 01/2012
4	Oropharyngeal Neoplasms 09/2020 - 01/2015
4	Endometrial Neoplasms (Endometrial Cancer) 08/2015 - 03/2002
4	Endometriosis 07/2014 - 08/2003
3	Overactive Urinary Bladder (Overactive Bladder) 02/2021 - 01/2020
3	Hypopharyngeal Neoplasms 01/2018 - 10/2010
3	Esophageal Neoplasms (Esophageal Cancer) 03/2017 - 01/2010
3	Pelvic Pain 12/2015 - 04/2010
3	Lymphatic Metastasis 03/2014 - 09/2004
2	Urolithiasis 04/2020 - 12/2019
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2019 - 02/2012
2	Laryngeal Neoplasms (Laryngeal Cancer) 01/2018 - 01/2016
2	Emergence Delirium 01/2018 - 01/2017
2	Breast Neoplasms (Breast Cancer) 01/2016 - 01/2003
2	Myoma 01/2016 - 09/2011
2	Carcinoid Tumor (Carcinoid) 01/2015 - 07/2013
2	Anemia 08/2014 - 01/2014
2	Leiomyoma (Uterine Fibroids) 09/2011 - 08/2003
2	Infertility (Sterility) 09/2010 - 04/2010
2	Primary Ovarian Insufficiency 03/2008 - 01/2007
1	Nocturia 03/2022

Drug/Important Bio-Agent (IBA)

18	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2012
11	Gonadotropin-Releasing Hormone (GnRH)FDA Link 05/2017 - 03/2002
8	Proteins (Proteins, Gene)FDA Link 08/2020 - 03/2002
6	Hormones (Hormone)IBA 01/2020 - 05/2002
5	Prostate-Specific Antigen (Semenogelase)IBA 10/2020 - 03/2003
5	Messenger RNA (mRNA)IBA 08/2020 - 03/2014
5	Gemcitabine FDA Link 02/2017 - 09/2006
5	Carboplatin (JM8)FDA LinkGeneric 02/2017 - 01/2008
5	GalaninIBA 01/2017 - 05/2013
4	ButyrylcholinesteraseIBA 02/2018 - 01/2014
4	Estrogens (Estrogen)FDA Link 01/2016 - 01/2003
4	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 11/2003 - 03/2002
3	Advanced Glycation End ProductsIBA 03/2022 - 01/2021
3	Circulating Tumor DNAIBA 01/2022 - 01/2020
3	Pharmaceutical PreparationsIBA 08/2021 - 01/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 11/2018
3	EnzymesIBA 01/2019 - 07/2004
3	alpha2 Subunit Collagen Type IIBA 01/2018 - 01/2012
3	Cisplatin (Platino)FDA LinkGeneric 02/2017 - 01/2013
3	Galanin Receptors (Galanin Receptor)IBA 02/2016 - 06/2013
3	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 05/2005 - 11/2003
2	ORALIT (ORS)IBA 01/2022 - 07/2014
2	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 02/2019
2	5-hydroxymethylcytosineIBA 01/2021 - 01/2019
2	Serum AlbuminIBA 04/2020 - 11/2018
2	ProstaglandinsIBA 01/2020 - 01/2003
2	Neuropeptide Receptors (Neuropeptide Receptor)IBA 01/2020 - 09/2017
2	NucleotidesIBA 01/2020 - 01/2010
2	Indicators and Reagents (Reagents)IBA 12/2019 - 07/2017
2	somatostatin receptor type 1IBA 01/2018 - 01/2015
2	suvorexantIBA 01/2018 - 01/2017
2	ramelteon (Rozerem)FDA Link 01/2018 - 01/2017
2	Iodine-125IBA 12/2017 - 11/2016
2	Estramustine FDA Link 05/2017 - 04/2014
2	H-cadherin (T-cadherin)IBA 05/2016 - 01/2012
2	Cadherins (E-Cadherin)IBA 05/2016 - 05/2013
2	Leuprolide (Lupron)FDA LinkGeneric 01/2016 - 09/2011
2	Buserelin (Suprefact)IBA 01/2016 - 05/2002
2	Docetaxel (Taxotere)FDA Link 12/2015 - 02/2012
2	Axitinib (AG 013736)IBA 04/2015 - 11/2013
2	Tachykinin Receptors (Tachykinin Receptor)IBA 01/2015 - 05/2013
2	Interleukin-6 (Interleukin 6)IBA 11/2014 - 03/2004
2	C-Reactive ProteinIBA 08/2014 - 01/2014
2	CollagenIBA 03/2014 - 01/2012
2	Tumor Biomarkers (Tumor Markers)IBA 01/2014 - 04/2012
2	lysophosphatidic acidIBA 07/2004 - 03/2004
2	Serine (L-Serine)FDA Link 12/2003 - 11/2003
2	Threonine (L-Threonine)FDA Link 12/2003 - 11/2003

Therapy/Procedure

22	Therapeutics 01/2021 - 01/2008
13	Radiotherapy 10/2020 - 03/2003
13	Drug Therapy (Chemotherapy) 11/2018 - 01/2007
10	Cystectomy 02/2021 - 02/2009
8	Prostatectomy (Retropubic Prostatectomy) 01/2020 - 03/2008
6	Transurethral Resection of Bladder 01/2021 - 01/2020
5	Neoadjuvant Therapy 04/2017 - 04/2014
4	Esophagectomy 01/2018 - 01/2016
4	Chemoradiotherapy 03/2017 - 09/2006
4	Lymph Node Excision (Lymph Node Dissection) 01/2016 - 03/2008
3	Castration 10/2020 - 01/2014
3	Brachytherapy 12/2017 - 01/2015
2	Neck Dissection (Radical Neck Dissection) 01/2020 - 12/2019
2	Nephrectomy 02/2017 - 01/2014
2	Combination Drug Therapy (Combination Chemotherapy) 04/2015 - 01/2008
2	Adrenalectomy 07/2013 - 07/2013
2	Laparotomy 07/2012 - 03/2008
2	Renal Dialysis (Hemodialysis) 01/2012 - 01/2011
2	Operative Surgical Procedures 09/2010 - 04/2010